Priyanka Raichur, MBBS, MPH

Pune, India
Role: 
Staff
Study Coordinator
Priyanka Raichur headshot

Dr. Priyanka Raichur, MBBS, MPH is a Study Coordinator/Clinician at the BJGMC-JHU Clinical Research Site, Pune, India. She is currently working on the PREEMPT study, which aims to evaluate the predictors of emergence of resistance among adult MDR TB patients. She is also handling the BEAT TB Asia study which is an interrupted time series mixed-methods aiming to identify a behavioral economics approach to overcome barriers to TPT delivery in public clinics in the Philippines, Indonesia and India, and the A5407 study, which is a Phase 3 multicenter randomized trial among adult COVID positive patients. Both these studies are in the preparatory phase.

During her 11-year tenure as clinician/coordinator at BJGMC-JHU CRS she has worked on several observational and interventional projects related to HIV-TB and infectious diseases in both adult and pediatric population. These include the Antimicrobial Resistance study (AMR), C-TRIUMPH study, TBDM study, ICMR – Pediatric TB project and the SHINE study, which was a large multicentric TB therapy shortening trial among Pediatric patients with minimal TB.

Dr. Priyanka completed her MBBS from Mahadevappa Rampure Medical College, Gulbarga, Karnataka, India and her MPH from MIT-WPU-Pune, India. She is currently a part of a cohort of global scholars of the Weill Cornell Medicine’s Women In Global Health Initiative program where she received training to improve skills as a global health researcher. Her research interests include adult HIV and Tuberculosis and Women’s health.

Virological Failure among People living with HIV Receiving Second-Line Antiretroviral Therapy in Pune, India

Post Date: 
2022-12-17
   |   
Countries: 
   |   
Clinical Sites: 
Publication: 
BMC Infectious Diseases
Background The number of people receiving second-line antiretroviral therapy (ART) has increased as global access to ART has expanded. Data on the burden and factors associated with second-line ART virologic failure (VF) from India remain limited. Methods We conducted cross-sectional viral load (VL...

How a Pune trial SHINEs light on shorter TB treatment for children

Post Date: 
2023-06-26
Source: 
The Indian Express
TB OPD at Sassoon hospital
Last year, based on SHINE research, the WHO strongly recommended shortening the TB treatment duration in non-severe paediatric TB cases from six-four months.